Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maike Zimmermann

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Proceedings of the National Academy of Sciences of the United States of America|May 7, 2009
mTOR supports long-term self-renewal and suppresses mesoderm and endoderm activities of human embryonic stem cellsJiaxi Zhou, Pei Su, Lu Wang, et al.
International Journal of Cancer|April 25, 2017
A diagnostic microdosing approach to investigate platinum sensitivity in non-small cell lung cancerSi-Si Wang, Maike Zimmermann, Hongyong Zhang, et al.
Molecular Cancer Therapeutics|February 8, 2020
Oxaliplatin-DNA Adducts as Predictive Biomarkers of FOLFOX Response in Colorectal Cancer: A Potential Treatment Optimization StrategyMaike Zimmermann, Tao Li, Thomas J Semrad, et al.
Molecular Cancer Therapeutics|December 2, 2016
Microdose-Induced Drug-DNA Adducts as Biomarkers of Chemotherapy Resistance in Humans and MiceMaike Zimmermann, Si-Si Wang, Hongyong Zhang, et al.
Plos One|January 23, 2016
Molecular Dissection of Induced Platinum Resistance through Functional and Gene Expression Analysis in a Cell Culture Model of Bladder CancerSisi Wang, Hongyong Zhang, Tiffany M Scharadin, et al.
Toxics|May 12, 2019
Radiocarbon Tracers in Toxicology and Medicine: Recent Advances in Technology and ScienceMichael A Malfatti, Bruce A Buchholz, Heather A Enright, et al.
Molecular Cancer Therapeutics|December 30, 2017
COX-2/sEH Dual Inhibitor PTUPB Potentiates the Antitumor Efficacy of CisplatinFuli Wang, Hongyong Zhang, Ai-Hong Ma, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Proceedings of the National Academy of Sciences of the United States of America|May 7, 2009
mTOR supports long-term self-renewal and suppresses mesoderm and endoderm activities of human embryonic stem cellsJiaxi Zhou, Pei Su, Lu Wang, et al.
International Journal of Cancer|April 25, 2017
A diagnostic microdosing approach to investigate platinum sensitivity in non-small cell lung cancerSi-Si Wang, Maike Zimmermann, Hongyong Zhang, et al.
Molecular Cancer Therapeutics|February 8, 2020
Oxaliplatin-DNA Adducts as Predictive Biomarkers of FOLFOX Response in Colorectal Cancer: A Potential Treatment Optimization StrategyMaike Zimmermann, Tao Li, Thomas J Semrad, et al.
Molecular Cancer Therapeutics|December 2, 2016
Microdose-Induced Drug-DNA Adducts as Biomarkers of Chemotherapy Resistance in Humans and MiceMaike Zimmermann, Si-Si Wang, Hongyong Zhang, et al.
Plos One|January 23, 2016
Molecular Dissection of Induced Platinum Resistance through Functional and Gene Expression Analysis in a Cell Culture Model of Bladder CancerSisi Wang, Hongyong Zhang, Tiffany M Scharadin, et al.
Toxics|May 12, 2019
Radiocarbon Tracers in Toxicology and Medicine: Recent Advances in Technology and ScienceMichael A Malfatti, Bruce A Buchholz, Heather A Enright, et al.
Molecular Cancer Therapeutics|December 30, 2017
COX-2/sEH Dual Inhibitor PTUPB Potentiates the Antitumor Efficacy of CisplatinFuli Wang, Hongyong Zhang, Ai-Hong Ma, et al.
Pageof 2